News - Galenica


Current filters:


Popular Filters

Vifor gets certain rights to Helsinn's netupitant-palonosetron


Privately-held Helsinn Healthcare and fellow Switzerland-based Vifor Pharma, part of the Galenica group…

EisaiEuropeGalenicaHelsinnLicensingnetupitantOncologypalonosetronPharmaceuticalVifor Pharma

US FDA sets new PDUFA action date for Vifor's Injectafer NDA


Vifor Pharma, a unit of Switzerland's Galenica Group (SIX: GALN), says that its US partner, Luitpold…

Daiichi SankyoFerinjectGalenicaInjectaferLuitpold PharmaNorth AmericaPharmaceuticalRegulationVifor Pharma

Vifor Fresenius PA21 filed for approval with US FDA, accepted by EMA


A New Drug Application for PA21 (iron(III)-oxyhydroxide) has been submitted to the US Food and Drug Administration.…

EuropeFreseniusGalenicaNephrology and HepatologyNorth AmericaPA21PharmaceuticalRegulationVifor Pharma

Observational study suggests a role for Vifor's Ferinject for anemic and iron deficient patients with cancer


Swiss firm Vifor Pharma, a subsidiary of the Galenica Group (GALN: SIX), notes the publication of an…

FerinjectGalenicaOncologyPharmaceuticalResearchVifor Pharma

Regulatory filing preparations underway for Vifor's PA21 on good Ph III results


The pivotal Phase III clinical study shows that the new phosphate binder PA21 successfully controls hyperphosphatemia…

FreseniusGalenicaNephrology and HepatologyPA21PharmaceuticalRegulationResearchVifor Pharma

Vifor to distribute Debiopharm's Pamorelin in Switzerland


Swiss independent drug developer Debiopharm) and Switzerland-based Vifor Pharma - part of Galenica (SIX:…

DebiopharmEuropeGalenicaLicensingMen's HealthOncologyPamorelinPharmaceuticalSalvacylVifor Pharma

Galenica acquires Spanish JV Vifor Uriach and Grupo Uriach's primary care business


Swiss drugmaker Galenica (SIX: GALN) has acquired all the outstanding shares of Vifor Uriach Pharma SL,…

GalenicaMergers & AcquisitionsPharmaceuticalUriach

Vifor Pharma ties up with Hikma for Ferinject in Middle East and North Africa


Switzerland-based Vifor Pharma, a subsidiary of the Galenica Group (GALN: SIX), has entered into a collaboration…

FerinjectFinancialGalenicaHikma PharmaceuticalsLicensingPharmaceuticalRest of the WorldVifor Pharma

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top